COVID-19 Combination Clinical Study

May 12, 2020

COVID-19 Combination Clinical Study

Beaumont Health has launched a new clinical study aimed at treating COVID-19 patients with a combination of naltrexone and ketamine. In spite of the challenges associated with the pandemic, Yourway is maintaining operations across our global network.

Back to Index

Media

Upcoming Event

BIO International Convention

June 8-11, 2020
San Diego, CA, USA (Virtual)

Schedule a Meeting

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat

Hello! How can I help you?